Alnylam Pharmaceuticals (ALNY) PT Lowered to $345 at RBC Capital
RBC Capital analyst Luca Issi ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)